Caplin Point Laboratories has received an approval for an investment in a step down subsidiary at El Salvador up to a limit of $7 million in Ordinary Shares and/ or Debt by its Wholly Owned Subsidiary i.e. Caplin Point Far East. The Board of Directors of the company at their meeting held on August 06, 2018, approved the same.
Caplin Point Laboratories is engaged mainly in manufacturing a wide range of Ointments, Creams and other External application preparations in addition to the regular segments of pharmaceutical formulations.
